BioCentury
ARTICLE | Finance

Quogue capitalizes Calistoga: Cancer play Calistoga adds $40M from VCs on top of $30M in 2009

July 5, 2010 7:00 AM UTC

Wayne Rothbaum of Quogue Capital ventured out of his usual territory of biotech public market investment to lead last week's $40 million series C round for cancer and inflammatory disease company Calistoga Pharmaceuticals Inc.

New investor Latterell Venture Partners also joined the deal, along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners...